Status:
WITHDRAWN
A Study To Assess The Safety And Effectiveness Of Medrol® In Acute Asthma In Indian Patients
Lead Sponsor:
Pfizer
Conditions:
Asthma
Eligibility:
All Genders
Brief Summary
The present study is designed to collect data on real world experience on use of Medrol in acute asthma in Indian patients.
Detailed Description
Sequential enrollment
Eligibility Criteria
Inclusion
- To be eligible for enrollment in this study, patients must be prescribed oral Medrol® tablets (4mg and 16 mg) for acute asthma as per the locally approved prescribing information. The prescription of Medrol® will be separated from the decision to include the patient in the study.
- Medrol® tablets, will be prescribed to the patient by the physician according to his/her usual practice. The decision to prescribe Medrol® tablet will necessarily precede and will be independent of the decision to enroll patient into the study. Only those patients who have been prescribed Medrol® tablets will be evaluated for their potential eligibility for the study
- Only those patients, who are ready and willing to sign an informed consent, will be included in the study
- Subject can be contacted through telephone
Exclusion
- Based upon history or physical exam in the emergency department (ED) or Clinic, subjects with known or suspected cause of pulmonary symptoms other than asthma, such as COPD, CHF, pneumonia, pulmonary embolism, or angioedema
- Any contraindication to Medrol tablet use. Contraindications of Medrol use are systemic fungal infections and known hypersensitivity to components
Key Trial Info
Start Date :
October 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2010
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00971893
Start Date
October 1 2009
End Date
April 1 2010
Last Update
November 29 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.